John Ransom
Stock Analyst at Raymond James
(3.72)
# 653
Out of 4,829 analysts
226
Total ratings
64.8%
Success rate
15.47%
Average return
Main Sectors:
Stocks Rated by John Ransom
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $380.64 | +41.87% | 13 | Apr 21, 2025 | |
RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $55.74 | +16.61% | 11 | Mar 5, 2025 | |
CI The Cigna Group | Reiterates: Strong Buy | $415 → $360 | $333.46 | +7.96% | 17 | Jan 31, 2025 | |
HCA HCA Healthcare | Downgrades: Market Perform | n/a | $353.70 | - | 21 | Nov 22, 2024 | |
THC Tenet Healthcare | Downgrades: Outperform | $195 | $148.83 | +31.02% | 17 | Nov 22, 2024 | |
CYH Community Health Systems | Downgrades: Underperform | n/a | $3.50 | - | 8 | Nov 22, 2024 | |
SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $75.87 | +12.03% | 12 | Nov 1, 2024 | |
GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.32 | +131.48% | 2 | May 16, 2024 | |
EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $116.41 | -18.39% | 15 | Apr 26, 2024 | |
WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.22 | - | 7 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $95.30 | - | 14 | Mar 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $249.53 | - | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $17.11 | +16.89% | 1 | Mar 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $25.62 | +17.10% | 12 | Mar 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $15.12 | -20.61% | 9 | Jan 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $66.97 | +26.92% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $110.91 | -5.33% | 8 | Aug 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $2.99 | +234.45% | 4 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.40 | - | 7 | May 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.13 | - | 11 | May 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.07 | - | 7 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $23.84 | +319.46% | 8 | Aug 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $44.27 | - | 2 | Feb 14, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $27.84 | - | 2 | Dec 20, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $143.76 | - | 8 | Nov 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $22.16 | - | 2 | Aug 9, 2017 |
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $380.64
Upside: +41.87%
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $55.74
Upside: +16.61%
The Cigna Group
Jan 31, 2025
Reiterates: Strong Buy
Price Target: $415 → $360
Current: $333.46
Upside: +7.96%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $353.70
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $148.83
Upside: +31.02%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.50
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $75.87
Upside: +12.03%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.32
Upside: +131.48%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $116.41
Upside: -18.39%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.22
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $95.30
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $249.53
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $17.11
Upside: +16.89%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $25.62
Upside: +17.10%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $15.12
Upside: -20.61%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $66.97
Upside: +26.92%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $110.91
Upside: -5.33%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $2.99
Upside: +234.45%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.40
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.13
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $23.07
Upside: -
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $23.84
Upside: +319.46%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $44.27
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $27.84
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $143.76
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $22.16
Upside: -